AZ’ Farxiga shows 47% reduction in kidney function decline

13th June 2019 Uncategorised 0

The SGLT2 inhibitor was evaluated in 17,160 patients with type II diabetes.

More: AZ’ Farxiga shows 47% reduction in kidney function decline
Source: News